Neuralstem Appoints David J. Mazzo, Ph.D., to Board of Directors

Autor: PR Newswire
Zdroj: PR Newswire US. 05/06/2019.
Abstrakt: GERMANTOWN, Md., May 6, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule technologies, announced that David J. Mazzo, Ph.D. has been appointed to the Company's Board of Directors to be effective June 12, 2019. Dr. Mazzo will replace Stanley Westreich, who is retiring on the effective date. [ABSTRACT FROM PUBLISHER]
Databáze: Regional Business News
Nepřihlášeným uživatelům se plný text nezobrazuje